---
title: "Kailera Therapeutics: The record-breaking obesity IPO big pharma cannot ignore"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296242784.md"
description: "Kailera Therapeutics, following a record-breaking obesity IPO and subsequent stock drop, is viewed as an attractive acquisition target for major pharmaceutical companies like Pfizer, AstraZeneca, and Merck. The company holds significant cash reserves and a strategic partnership with Jiangsu Hengrui Pharmaceuticals, which retains rights in greater China while Kailera controls ex-Greater China territories. With pivotal trial data expected between 2027 and 2028, analysts suggest big pharma may acquire Kailera to secure its GLP-1/GIP pipeline assets before commercial milestones are realized."
datetime: "2026-08-18T14:24:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296242784.md)
  - [en](https://longbridge.com/en/news/296242784.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296242784.md)
generator: "portal-rs"
---

# Kailera Therapeutics: The record-breaking obesity IPO big pharma cannot ignore

Quick ReadKLRA trades 29% below its IPO high but holds $1.17 billion in cash and carries a $42 analyst consensus price target.Merck's looming Keytruda revenue cliff and Novo Nordisk's need to defend Wegovy dominance make both natural buyers of Kailera's GLP-1 pipeline.Any acquirer secures U.S., European, and Japanese rights but inherits up to $5.7 ...

### Related Stocks

- [KLRA.US](https://longbridge.com/en/quote/KLRA.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)
- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [TCW Group Inc. Trims Stake in Pfizer Inc. $PFE](https://longbridge.com/en/news/296204181.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [Pfizer (PFE) Reaches Deal Covering About 5,000 Federal Lawsuit Claims](https://longbridge.com/en/news/296430772.md)
- [Independent Financial Group LLC Purchases 57,994 Shares of Pfizer Inc. $PFE](https://longbridge.com/en/news/295997450.md)
- [Diversified Trust Co. Has $3.64 Million Stock Holdings in Pfizer Inc. $PFE](https://longbridge.com/en/news/296071353.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**